X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
xenografted caki-1 tumors (7) 7
antitumor-activity (4) 4
chemistry, medicinal (3) 3
mice (3) 3
titanium dichloride (3) 3
animals (2) 2
anticancer drugs (2) 2
cancer (2) 2
chemistry, inorganic & nuclear (2) 2
chemistry, multidisciplinary (2) 2
cisplatin (2) 2
cytotoxicity (2) 2
derivatives (2) 2
in-vitro (2) 2
thioredoxin reductase (2) 2
titanocene dichloride (2) 2
ab-initio pseudopotentials (1) 1
antibacterial (1) 1
anticancer drug (1) 1
antineoplastic agents - chemistry (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents - therapeutic use (1) 1
antiproliferative activities (1) 1
antiproliferative activity (1) 1
apoptosis (1) 1
benzyl (1) 1
biochemical engineering (1) 1
biocompatibility (1) 1
biological evaluation (1) 1
biological-properties (1) 1
biotechnology (1) 1
caki-1 (1) 1
caki-1 renal cell cancer (1) 1
cancer research (1) 1
cancer-cells (1) 1
carbene-gold anticancer drug (1) 1
carbene-silver acetate complexes (1) 1
carbolithiation (1) 1
care and treatment (1) 1
cells (1) 1
cells in-vitro (1) 1
chemical properties (1) 1
chemistry (1) 1
chemistry, inorganic (1) 1
chemistry, organic (1) 1
chemistry, pharmaceutical (1) 1
chemotherapy (1) 1
clinical trials (1) 1
clinical trials as topic (1) 1
cobalt-alkyne complexes (1) 1
colony-forming-units (1) 1
coordination complexes - chemistry (1) 1
coordination complexes - pharmacology (1) 1
coordination complexes - therapeutic use (1) 1
crystallography (1) 1
cytotoxic activity (1) 1
density (1) 1
dichloride derivatives (1) 1
dna-binding properties (1) 1
enhanced bone-resorption (1) 1
environment (1) 1
estrogen-receptor modulators (1) 1
ferrocenyl tamoxifen derivatives (1) 1
fulvene (1) 1
fulvenes (1) 1
gene expression (1) 1
glucose transporter (1) 1
heterocyclic carbene complexes (1) 1
human serum transferrin (1) 1
humans (1) 1
hydridolithiation (1) 1
inhibitors (1) 1
kinase-c-iota (1) 1
kinases (1) 1
l-ascorbic-acid (1) 1
llc-pk (1) 1
mathematical models (1) 1
medicinal chemistry (1) 1
metal-complexes (1) 1
metallocene antitumor agents (1) 1
metallocenes (1) 1
nanotechnology (1) 1
nci 60 cancer cell panel (1) 1
neoplasms - drug therapy (1) 1
organometallic chemistry (1) 1
organometallic compounds (1) 1
oxali-titanocene-y (1) 1
particulate wear debris (1) 1
pharmaceutical sciences/technology (1) 1
platinum complexes (1) 1
proteins (1) 1
pyrrole (1) 1
renal-cell cancer (1) 1
research (1) 1
series (1) 1
strain gin-1 ncimb-40340 (1) 1
structure (1) 1
substituted titanocene (1) 1
substituted titanocenes (1) 1
surgical implants (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medicinal chemistry (Shp-sariqah, United Arab Emirates), ISSN 1573-4064, 2017, Volume 13, Issue 4, pp. 334 - 344
Background: Enormous success of antitumor agent cisplatin initiated interest in other organometallic complexes. A subclass of organometallic compounds termed... 
CANCER-CELLS | titanocene compounds | ANTIPROLIFERATIVE ACTIVITY | CHEMISTRY, MEDICINAL | CELLS IN-VITRO | ANTITUMOR-ACTIVITY | CYTOTOXIC ACTIVITY | PLATINUM COMPLEXES | organometallic compounds | XENOGRAFTED CAKI-1 TUMORS | Chemotherapy | SUBSTITUTED TITANOCENE | clinical trials | TITANIUM DICHLORIDE | cisplatin | DICHLORIDE DERIVATIVES | titanocene dichloride
Journal Article
Chemical science (Cambridge), ISSN 2041-6520, 2015, Volume 6, Issue 9, pp. 5269 - 5283
Heterometallic compounds as anticancer agents demonstrating potential for the first time. Titanocene–gold derivatives: promising candidates for renal cancer.... 
TRANSITION-ELEMENTS | XENOGRAFTED CAKI-1 TUMORS | TRANSFORMED GROWTH | TITANOCENE ANTICANCER DRUGS | THIOREDOXIN REDUCTASE | ANTITUMOR-ACTIVITY | AB-INITIO PSEUDOPOTENTIALS | BIOLOGICAL-PROPERTIES | CHEMISTRY, MULTIDISCIPLINARY | KINASE-C-IOTA | METAL-COMPLEXES | Proteins | Surgical implants | Biotechnology | Biocompatibility | Mathematical models | Mice | Kinases | Cancer
Journal Article
Letters in Drug Design and Discovery, ISSN 1570-1808, 2016, Volume 14, Issue 2, pp. 125 - 134
... and 7.5 mg/kg for NHC-AuSR were determined with single injections to groups of 2 mice. In the following tumor xenograft experiment NHC-AuCl and NHC-AuSR were given at MTD in 6 injections to two cohorts of 6 CAKI-1 tumor-bearing... 
Glucose transporter | Carbene-gold anticancer drug | CAKI-1 renal cell cancer | NCI 60 cancer cell panel | Xenograft mouse model | Thioredoxin reductase | CHEMISTRY, MEDICINAL | ANTIBACTERIAL | thioredoxin reductase | DENSITY | XENOGRAFTED CAKI-1 TUMORS | BENZYL | xenograft mouse model | glucose transporter | CARBENE-SILVER(I) ACETATE COMPLEXES | BIOLOGICAL EVALUATION | ANTIPROLIFERATIVE ACTIVITIES | INHIBITORS | CYTOTOXICITY | DERIVATIVES
Journal Article
Polyhedron, ISSN 0277-5387, 2010, Volume 29, Issue 12, pp. 2445 - 2453
Four pyrrolyl-substituted titanocene dichloride complexes were synthesised and one derivative could be characterised by X-ray diffraction. In addition, all... 
Anticancer drug | Titanocene dichloride | Cytotoxicity | CAKI-1 | Renal-cell cancer | Pyrrole | FULVENES | CELLS | APOPTOSIS | CRYSTALLOGRAPHY | ANTITUMOR-ACTIVITY | CHEMISTRY, INORGANIC & NUCLEAR | XENOGRAFTED CAKI-1 TUMORS | ANTICANCER DRUGS | MICE | TITANIUM DICHLORIDE | Care and treatment | Metallocenes | Cancer
Journal Article
2010, Topics in Organometallic Chemistry, ISBN 9783642131844, Volume 32, 22
Book Chapter
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.